Back to User profile » Professor Reynold Panettieri Jr
Papers published by Professor Reynold Panettieri Jr:
Mortality Among Adults with Subspecialist-Treated Severe Asthma: A Descriptive Analysis from the Observational CHRONICLE Study
Lugogo NL, Trevor J, Spahn JD, Panettieri RA Jr, Carstens DD, Ambrose CS
Journal of Asthma and Allergy 2026, 19:588118
Published Date: 5 May 2026
Leveraging Machine Learning and Real-World Data to Predict Chronic Obstructive Pulmonary Disease Exacerbations
Panettieri RA Jr, Roy J, Gontarczyk Uczkowski N, Tyler A, Attanucci J, O’Riordan TG, Kahle-Wrobleski K
International Journal of Chronic Obstructive Pulmonary Disease 2025, 20:3451-3459
Published Date: 31 October 2025
Through a Translational Lens: How Does Inflammation Contribute to the Pathogenesis of Asthma and Allergy?
Koziol-White CJ, Panettieri Jr RA
Journal of Inflammation Research 2025, 18:11189-11190
Published Date: 15 August 2025
Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types
Panettieri R Jr, Lugogo N, Corren J, Ambrose CS
Journal of Asthma and Allergy 2024, 17:219-236
Published Date: 19 March 2024
Long-Term Use of Maintenance Systemic Corticosteroids is Associated with Multiple Adverse Conditions in a Large, Real-World Cohort of US Adults with Severe Asthma
Lugogo N, Chipps BE, Panettieri RA Jr, Trudo F, Ambrose CS
Journal of Asthma and Allergy 2022, 15:1753-1761
Published Date: 7 December 2022
Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial
Panettieri Jr RA, Camargo CA Jr, Cheema T, El Bayadi SG, Fiel S, Vila TM, Jain RG, Midwinter D, Thomashow B, Ludwig-Sengpiel A, Lipson DA
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2043-2052
Published Date: 1 September 2022
Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation
Hanania NA, Maspero JF, Halpin DM, Jackson DJ, Panettieri RA, Castro M, Domingo C, Daizadeh N, Gall R, Jacob-Nara JA, Ortiz B, Djandji M, Rowe PJ, Deniz Y
Journal of Asthma and Allergy 2022, 15:851-854
Published Date: 28 June 2022
The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results
Ambrose CS, Chipps BE, Moore WC, Soong W, Trevor J, Ledford DK, Carr WW, Lugogo N, Trudo F, Tran TN, Panettieri RA Jr
Pragmatic and Observational Research 2020, 11:77-90
Published Date: 16 July 2020
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]
Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ
Journal of Asthma and Allergy 2020, 13:135-136
Published Date: 13 March 2020
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA)
Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ
Journal of Asthma and Allergy 2020, 13:115-126
Published Date: 17 February 2020